General Information
Revision date
2015-12-17
Product name
‘Section.1.-Identification, "7"
CAS No.
99614-01-4
1.2.2. Uses advised against
No other uses are advised
supplier name
Canada
Emergency telephone
1-800-424-9300, +1 703-527-3887, 1-(416)-749-9300
Icons in SDS
Company Information
company name
Canada
Section 2
SECTION 2: Hazards identification
1272/2008 - eS , e ee E = so ca " r . * ee the 8 + ‘ ne Bf . # # AYE oe ® set a aa £ a, Boe ar) “eto Oy sae is ~” Classification of
2.2 Label elements
Exempt from requirements.
2.3 Other hazards
Exempt from requirements. Séction'3." Coniposition/Information-ofi Ingrediénts., Bi ae &, ae Y sgt te wee a ae ee a ae . A wet gh es a & ; . * ae “ " ." ‘ + 2 ta By htbetes oP er Pe ee eo. ut 4 aie os Ey oF vg Z Name eee 2 CAS # % (wiw) Ondansetron hydrochloride 99614-01-4 | 0.5 Specific chemical identity and/or percentage of composition has been withheld as a trade secret. Chemical name Not available. Synonyms Not available, Chemical family - Not available. Molecular Not applicable weight Chemical Not applicable. Formula | Continued on Next Page Revision date: 12/17/2015 | rm eu ee cee ee ee a a eR I a | Ondansetron Hydrochloride Injection, Solution; Ondansetron Injection USP (2 mg/mL) Page Number: 2 | .* ry wo. ape Roe road ot cy / co ag FS
2.1 Classification of the substance or mixture
As per 29 CFR 1910.1200 (b)(6) and according to Article 1, item * of CLP Regulation (EC) 1272/2008, the substance or medicinal products (drugs) when it is in the solid, final form for dir t administration to the patient or are packaged by the manufacturer for sale to consumers in a retail establishmen mixture are exempt from the requirements of classification, labels and SDS's. GHS label elements
